Skip to main content
. 2010 Dec 27;2010:539461. doi: 10.1155/2010/539461

Table 2.

Genotype and allele counts for IL-12B and IL-23R variants in CD patients and in Caucasian controls.

Control n (%) Case n (%) OR (95% CI) P
IL-12B C/C 10 (2.9) 11 (3.6) 1.30 (0.54–3.12) .638
rs1363670 C/G 71 (20.8) 70 (23.3) 1.17 (0.80–1.70)
G/G 260 (76.3) 220 (73.1) 1.00
HWE 0.10 0.08
Cochran-Armitage Trend for G Z = −0.95, Pr < Z 0.172
C 91 (13.3) 92 (15.3) 1.17 (0.86–1.60) .338
G 591 (86.7) 510 (84.7) 1.00

IL-12B C/C 39 (10.8) 29 (9.2) 0.79 (0.47–1.35) .625
rs6887695 C/G 177 (48.9) 148 (47.1) 0.89 (0.65–1.23)
G/G 146 (40.3) 137 (43.6) 1.00
HWE 0.21 0.25
C 255 (35.2) 206 (32.8) 0.90 (0.72–1.13) .358
G 469 (64.8) 422 (67.2) 1.00

IL-23R A/A 45 (12.5) 37 (11.8) 1.18 (0.72–1.93) .030
rs10889677 A/C 146 (40.6) 158 (50.5) 1.55 (1.12–2.15)
C/C 169 (46.9) 118 (37.7) 1.00
HWE 0.15 0.18
A 236 (32.8) 232 (37.1) 1.21 (0.96–1.52) .100
C 484 (67.2) 394 (62.9) 1.00

IL-23R A/A 5 (0.8) 0 (0)
rs11209026 A/G 75 (11.9) 28 (8.0) 0.64 (0.41–1.01) .164
G/G 553 (87.4) 321 (92.0) 1.00
HWE 0.19 1.00
Cochran-Armitage Trend for G Z = 2.42, Pr > Z 0.008
A 85 (6.7) 28 (4.0) 0.58 (0.37–0.90) .015
G 1181 (93.3) 670 (96.0) 1.00

IL-23R C/C 173 (47.3) 123 (39.3) 1.00 .108
rs11805303 C/T 158 (43.2) 153 (48.9) 1.36 (0.99–1.88)
T/T 35 (9.6) 37 (11.8) 1.49 (0.89–2.49)
HWE 1.00 0.33
T 228 (31.1) 227 (36.3) 1.26 (1.01–1.58) .049
C 504 (68.9) 399 (63.7) 1.00

IL-23R A/A 56 (15.2) 16 (5.1) 0.29 (0.16–0.53) .0002
rs1343151 A/G 154 (41.7) 142 (45.4) 0.95 (0.69–1.30)
G/G 159 (43.1) 155 (49.5) 1.00
HWE 0.07 0.02
Cochran-Armitage Trend for G Z = 3.24, Pr > Z 0.0006
A 266 (36.0) 174 (27.8) 0.68 (0.54–0.86) .001
G 472 (64.0) 452 (72.2) 1.00

IL-23R G/G 72 (19.6) 29 (9.4) 0.42 (0.25–0.70) .001
rs7517847 G/T 183 (49.7) 172 (55.7) 0.98 (0.70–1.38)
T/T 113 (30.7) 108 (34.9) 1.00
HWE 0.92 0.001
G 327 (44.4) 230 (37.2) 0.74 (0.59–0.92) .007
T 409 (55.6) 388 (62.8) 1.00